The NATF Atrial Fibrillation Action Initiative is a 3-year project to identify multidisciplinary best practices for stroke prevention in atrial fibrillation (AF). Our mission is to provide a comprehensive yet concise consensus briefing document focused on stroke and bleeding risk assessment in patients with AF, as well as recommendations regarding anticoagulation options and management. We intend this cohesive and practical educational document to serve as a reference for the entire medical community involved in the care of patients with AF: primary care, emergency medicine, pharmacology, and cardiovascular medicine.

Despite the recent increase of clinical trial data and guideline recommendation updates, many clinicians struggle to synthesize the disparate information, inhibiting utilization of updated risk prediction tools and adoption of novel oral anticoagulants. The goal of the AF Action Initiative is to synthesize the current information into one usable resource for clinicians and patients.

The components of the AF Action Initiative include:

  • This dedicated AF Action Initiative micro-site for clinicians and patients, incorporating cutting edge literature and risk stratification tools
  • Video interviews with the leading clinical experts participating in the AF Action Initiative
  • A live consensus meeting of leading researchers, clinicians, and professional stakeholders that was held on May 12, 2014 in Boston, MA.
  • A comprehensive yet concise consensus document providing practical, real world advice concerning issues such as risk stratification, anticoagulation selection, and practical management scenarios
  • An in-depth supplement document providing supporting data

Dr. Piazza compares Novel Oral Anticoagulants.

Dr. Ruff presents the elements of NATF’s Atrial Fibrillation Action Initiative.

Dr. Goldhaber talks about the Atrial Fibrillation Action Initiative, and how it came to fruition.